high-risk
Showing 26 - 50 of >10,000
B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Azacitidine Injection
- +2 more
- (no location specified)
Oct 15, 2023
High-risk Features of Coronary Lesions in CTA and OCT
Active, not recruiting
- Acute Coronary Syndromes
- Coronary CT angiography
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
Oct 13, 2023
Suicide, Mental Health Disorder, Anhedonia Trial (Vira, Treatment as Usual (TAU))
Not yet recruiting
- Suicide
- +2 more
- Vira
- Treatment as Usual (TAU)
- (no location specified)
Jun 16, 2023
Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)
Not yet recruiting
- Prostate Cancer
- Newly-Diagnosed Prostate Cancer
- (no location specified)
Nov 3, 2023
Mpox in HIV Negative High Risk Sexual Health Clinic Attenders
Not yet recruiting
- Monkeypox
- HIV Coinfection
- No intervention
- (no location specified)
Jul 19, 2023
Postoperative Gastrointestinal Dysfunction After High Risk
Recruiting
- Gastrointestinal Dysfunction
- +2 more
-
Jakarta Pusat, Jakarta, IndonesiaCipto Mangunkusumo Central National Hospital
May 10, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Neural Tube Defects, Folic Acid Trial in Istanbul
Completed
- Neural Tube Defects
- Folic Acid
-
Istanbul, Sisli, TurkeyProf. Dr. Cemil Tascioglu City Hospital
Nov 13, 2023
High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)
Recruiting
- High-Risk Localized Soft Tissue Sarcoma
- Pegylated Liposomal Doxorubicin
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2023
Pressure-Volume Loop During High-Risk PCI
Recruiting
- Coronary Artery Disease
- High-risk percutaneous coronary intervention
-
Detroit, MichiganHenry Ford Hospital
Dec 6, 2022
Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- monoclonal antibodies GD2
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023
Patient Satisfaction Trial in Ramat Gan (un-sedated colonoscopies)
Completed
- Patient Satisfaction
- un-sedated colonoscopies
-
Ramat Gan, IsraelSheba medical center Tel Hashomer
Apr 24, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- ctDNA methylation dynamic monitoring
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 14, 2023
Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- High Risk
-
Houston, TexasHouston Methodist
Dec 8, 2022
Intermediate to High-risk Asymptomatic Sportsmen With Exercise
Completed
- Electrocardiography
- Screening stress test on a bicycle ergometer (usual practise)
-
Saint-Étienne, FranceCentre Hospitalier de Saint-Etienne
Sep 6, 2023
Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk
Recruiting
- Stimulant Abuse
- Criminal Behavior
- Decision task
-
Albuquerque, New MexicoThe Mind Research Network
Apr 25, 2023
Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Residual Disease
- Tetrathiomolybdate
- +2 more
- (no location specified)
Nov 15, 2023
Hepatocellular Carcinoma Trial in Tianjin (ultrasonic testing)
Recruiting
- Hepatocellular Carcinoma
- ultrasonic testing
-
Tianjin, Tianjin, China王芳
Nov 20, 2023
Among Patients Undergoing Acute High-risk Abdominal Surgery
Completed
- Abdomen, Acute
- +4 more
- Troponin I
-
Hillerød, DenmarkCopenhagen University Hospital - North Zealand
Aug 15, 2023
Breast Cancer Trial in Shanghai (Regional lymph node radiotherapy, chest/whole breast irradiation)
Recruiting
- Breast Cancer
- Regional lymph node radiotherapy
- chest/whole breast irradiation
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai jiaotong univestigy school of medicine
Aug 3, 2023
Liver Cirrhosis, Spontaneous Bacterial Peritonitis Trial in New Delhi (20% High Dose Albumin, Standard Medical Treatment, 20%
Not yet recruiting
- Liver Cirrhosis
- Spontaneous Bacterial Peritonitis
- 20% High Dose Albumin
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Sep 8, 2023
Feeding and Eating Disorders Trial (HAPTOS (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor
Not yet recruiting
- Feeding and Eating Disorders
- HAPTOS (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation
- (no location specified)
Sep 21, 2023
Lung Cancer, Lung Carcinoma Trial in Boston (Low-dose Computed Tomography)
Not yet recruiting
- Lung Cancer
- Lung Carcinoma
- Low-dose Computed Tomography
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jun 9, 2023